[go: up one dir, main page]

EA200801366A1 - Производные 3,6-дигидро-2-оксо-6н-1,3,4-тиадиазина - Google Patents

Производные 3,6-дигидро-2-оксо-6н-1,3,4-тиадиазина

Info

Publication number
EA200801366A1
EA200801366A1 EA200801366A EA200801366A EA200801366A1 EA 200801366 A1 EA200801366 A1 EA 200801366A1 EA 200801366 A EA200801366 A EA 200801366A EA 200801366 A EA200801366 A EA 200801366A EA 200801366 A1 EA200801366 A1 EA 200801366A1
Authority
EA
Eurasian Patent Office
Prior art keywords
tiadiazina
digidro
oxo
derivatives
compounds
Prior art date
Application number
EA200801366A
Other languages
English (en)
Other versions
EA015253B1 (ru
Inventor
Оливер Шадт
Дитер Дорш
Мелани Шультц
Андрее Блаукат
Original Assignee
Мерк Патент Гмбх
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Мерк Патент Гмбх filed Critical Мерк Патент Гмбх
Publication of EA200801366A1 publication Critical patent/EA200801366A1/ru
Publication of EA015253B1 publication Critical patent/EA015253B1/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/15—Six-membered rings
    • C07D285/16—Thiadiazines; Hydrogenated thiadiazines
    • C07D285/18—1,2,4-Thiadiazines; Hydrogenated 1,2,4-thiadiazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Соединения формулы I
EA200801366A 2005-11-21 2006-10-25 Производные 3,6-дигидро-2-оксо-6н-1,3,4-тиадиазина EA015253B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102005055355A DE102005055355A1 (de) 2005-11-21 2005-11-21 3,6-Dihydro-2-oxo-6H-[1,3,4]thiadiazinderivate
PCT/EP2006/010286 WO2007057093A1 (de) 2005-11-21 2006-10-25 3, 6-dihydro-2-oxo-6h-(1,3,4)thiadiazinderivate

Publications (2)

Publication Number Publication Date
EA200801366A1 true EA200801366A1 (ru) 2008-10-30
EA015253B1 EA015253B1 (ru) 2011-06-30

Family

ID=37758761

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200801366A EA015253B1 (ru) 2005-11-21 2006-10-25 Производные 3,6-дигидро-2-оксо-6н-1,3,4-тиадиазина

Country Status (21)

Country Link
US (1) US7534785B2 (ru)
EP (1) EP1963295B1 (ru)
JP (1) JP5227179B2 (ru)
KR (1) KR101424826B1 (ru)
CN (1) CN101312958A (ru)
AR (1) AR057899A1 (ru)
AT (1) ATE518848T1 (ru)
AU (1) AU2006314874B2 (ru)
BR (1) BRPI0618822A2 (ru)
CA (1) CA2630203C (ru)
CY (1) CY1112235T1 (ru)
DE (1) DE102005055355A1 (ru)
DK (1) DK1963295T3 (ru)
EA (1) EA015253B1 (ru)
ES (1) ES2367586T3 (ru)
IL (1) IL191361A (ru)
PL (1) PL1963295T3 (ru)
PT (1) PT1963295E (ru)
SI (1) SI1963295T1 (ru)
WO (1) WO2007057093A1 (ru)
ZA (1) ZA200805404B (ru)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102005055354A1 (de) * 2005-11-21 2007-10-31 Merck Patent Gmbh Substituierte 5-Phenyl-3,6-dihydro-2-oxo-6H-[1,3,4]thiadiazine
DE102007026341A1 (de) 2007-06-06 2008-12-11 Merck Patent Gmbh Benzoxazolonderivate
DE102007032507A1 (de) 2007-07-12 2009-04-02 Merck Patent Gmbh Pyridazinonderivate
DE102007041115A1 (de) * 2007-08-30 2009-03-05 Merck Patent Gmbh Thiadiazinonderivate
DE102007061963A1 (de) * 2007-12-21 2009-06-25 Merck Patent Gmbh Pyridazinonderivate
DE102008062826A1 (de) 2008-12-23 2010-07-01 Merck Patent Gmbh Pyridazinonderivate
GB201713962D0 (en) * 2017-08-31 2017-10-18 Ctxt Pty Ltd Compounds
GB201810092D0 (en) 2018-06-20 2018-08-08 Ctxt Pty Ltd Compounds
GB201810581D0 (en) 2018-06-28 2018-08-15 Ctxt Pty Ltd Compounds
IL288802B2 (en) 2019-06-18 2025-08-01 Pfizer Benzisoxazole sulfonamide derivatives
CN111454232B (zh) * 2020-05-30 2021-11-23 南方医科大学 一种1,3,4-噻二嗪类化合物及其应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19502699A1 (de) * 1995-01-28 1996-08-01 Merck Patent Gmbh Arylalkyl-thiadiazinone
DE19533975A1 (de) * 1995-09-14 1997-03-20 Merck Patent Gmbh Arylalkyl-diazinone
GB9525262D0 (en) * 1995-12-11 1996-02-07 Bayer Ag Heterocyclylcarbonyl substituted benzofuranyl-ureas
DE19604388A1 (de) * 1996-02-07 1997-08-14 Merck Patent Gmbh Arylalkyl-diazinone
DE10150517A1 (de) * 2001-10-12 2003-04-17 Merck Patent Gmbh Verwendung von Phosphodiesterase IV-Inhibitoren
HUP0401984A3 (en) * 2001-10-31 2005-06-28 Merck Patent Gmbh Use of type 4 phosphodiesterase inhibitors for preparation of pharmaceutical compositions and combination with other active ingredients
DE102005055354A1 (de) * 2005-11-21 2007-10-31 Merck Patent Gmbh Substituierte 5-Phenyl-3,6-dihydro-2-oxo-6H-[1,3,4]thiadiazine

Also Published As

Publication number Publication date
KR20080070768A (ko) 2008-07-30
SI1963295T1 (sl) 2011-09-30
IL191361A (en) 2013-11-28
AR057899A1 (es) 2007-12-26
CA2630203C (en) 2015-01-27
KR101424826B1 (ko) 2014-08-01
EP1963295A1 (de) 2008-09-03
ZA200805404B (en) 2009-11-25
EA015253B1 (ru) 2011-06-30
WO2007057093A1 (de) 2007-05-24
ES2367586T3 (es) 2011-11-04
CN101312958A (zh) 2008-11-26
CY1112235T1 (el) 2015-12-09
EP1963295B1 (de) 2011-08-03
US20080306052A1 (en) 2008-12-11
ATE518848T1 (de) 2011-08-15
JP2009516658A (ja) 2009-04-23
DK1963295T3 (da) 2011-09-26
AU2006314874B2 (en) 2012-01-19
CA2630203A1 (en) 2007-05-24
AU2006314874A1 (en) 2007-05-24
DE102005055355A1 (de) 2007-10-31
JP5227179B2 (ja) 2013-07-03
BRPI0618822A2 (pt) 2011-09-13
US7534785B2 (en) 2009-05-19
PL1963295T3 (pl) 2011-11-30
PT1963295E (pt) 2011-11-15

Similar Documents

Publication Publication Date Title
CY1109911T1 (el) Πυρρολοβενζοδιαζεπινες
EA200801428A1 (ru) Производные пиридиазинона для лечения опухолей
CY1112467T1 (el) Παραγωγα 1-θειο-d-γλυκιτολης
CY1111671T1 (el) Ετεροκυκλικη ενωση
UY29612A1 (es) Compuestos quimicos ii
EA200801381A1 (ru) Производные пиримидина
EA201000395A1 (ru) Фунгицидные производные 2-алкилтио-2-хинолинилоксиацетамида
EA201100875A1 (ru) Новые пиразол-4-n-алкоксикарбоксамиды в качестве микробиоцидов
MX342683B (es) Analogos de ciclopamina.
EA200800321A1 (ru) Ингибиторы гистондеацетилазы
ATE548374T1 (de) 2'-fluor-2'-desoxytetrahydrouridine als cytidindeaminaseinhibitoren
UA87153C2 (ru) Энантиомерно чистые аминогетероарильные соединения как ингибиторы протеинкиназы
MX2009009774A (es) Derivados de quinolina como fungicidas.
BRPI0608886B8 (pt) derivados de n-sulfonilpirróis e seus usos
ES2338590T3 (es) Procedimiento regioselectivo de preparacion de benzoimidazoltiofenos.
DK1761520T3 (da) Kinaseinhibitorer
EA200701396A1 (ru) Триазолофталазины в качестве ингибиторов pde-2
EA200900945A1 (ru) Новый способ синтеза агомелатина
ATE483000T1 (de) Naphtalin-amidin-imide
EA200801608A1 (ru) Производные бензимидазолонкарбоновой кислоты
EA200970372A1 (ru) Ингибитор развития болезни альцгеймера, содержащий гетероциклическое соединение
EA200900946A1 (ru) Новый способ синтеза агомелатина
UA106880C2 (uk) Нові гербіциди
EA201200891A1 (ru) Производные 3,4,4a,10d-тетрагидро-1h-тиопирано[4,3-c]изохинолина
NO20082105L (no) Pyrazoloisokinolinderivater

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG MD TJ TM